Showing results (321-330 of 340) with videos related to

Sort By:
Pageof 34
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 12, 2013
Obesity portends increased morbidity and earlier recurrence following liver transplantation for hepatocellular carcinomaAbhishek Mathur, Edson S Franco, John P Leone, et al.
Journal of the American College of Surgeons|August 30, 2005
Esophagography predicts favorable outcomes after laparoscopic Nissen fundoplication for patients with esophageal dysmotilityMatthew J D'Alessio, Steven Rakita, Mark Bloomston, et al.
Minerva Chirurgica|June 14, 2012
Evolution of segmental anesthesia for Laparo-Endoscopic Single Site (LESS) cholecystectomyS B Ross, D Mangar, R Karlnoski, et al.
The Journal of Surgical Research|August 25, 2007
Perspectives of third-year medical students toward their surgical clerkship and a surgical careerSteven B Goldin, Monika M Wahi, Lucas R Wiegand, et al.
The Journal of Surgical Research|July 4, 2006
Differential gene expression in patients genetically predisposed to pancreatic cancerEmmanuel E Zervos, Stephan M Tanner, Dana A Osborne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studiesJ Nemunaitis, C Poole, J Primrose, et al.
Annals of Surgical Oncology|January 9, 2008
An aggressive approach to extrahepatic cholangiocarcinomas is warranted: margin status does not impact survival after resectionJonathan Hernandez, Sarah M Cowgill, Sam Al-Saadi, et al.
Annals of Surgery|May 29, 2004
TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites: a prospective randomized trialAlexander S Rosemurgy, Emmanuel E Zervos, Whalen C Clark, et al.
Annals of Surgical Oncology|March 3, 2006
Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumorsDana A Osborne, Emmanuel E Zervos, Jonathan Strosberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2006
Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter studyD A Richards, K A Boehm, D M Waterhouse, et al.
Pageof 34